Epicenters for the Prevention of Healthcare Associated Infections, Antimicrobial Resistance and Adverse Events

The summary for the Epicenters for the Prevention of Healthcare Associated Infections, Antimicrobial Resistance and Adverse Events grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention, which is the U.S. government agency offering this grant.

Epicenters for the Prevention of Healthcare Associated Infections, Antimicrobial Resistance and Adverse Events: The CDC Prevention Epicenters Program has been established to develop, implement and evaluate the effectiveness of epidemiologically-based strategies to improve healthcare quality and patient safety. This funding opportunity announcement is designed to utilize the CDC Prevention Epicenters Program to translate basic, epidemiologic and technologic discoveries into new strategies for improving prevention of HAIs, Antimicrobial resistance (AR) and other adverse events in all types of healthcare facilities in the United States.

Federal Grant Title:	Epicenters for the Prevention of Healthcare Associated Infections, Antimicrobial Resistance and Adverse Events
Federal Agency Name:	Centers for Disease Control and Prevention
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-CK-16-004
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.084
CFDA Descriptions:	Prevention of Disease, Disability, and Death by Infectious Diseases
Current Application Deadline:	Jan 15, 2016 Electronically submitted application
Original Application Deadline:	Jan 15, 2016 Electronically submitted application
Posted Date:	Oct 28, 2015
Creation Date:	Oct 28, 2015
Archive Date:	Feb 14, 2016
Total Program Funding:	$24,000,000
Maximum Federal Grant Award:	$500,000
Minimum Federal Grant Award:	$400,000
Expected Number of Awards:	5
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Additional Information on Eligibility:
Only the awardees of CDC FOA CK11-001 are eligible to apply.

Harvard Pilgrim Healthcare Inc.
Duke University
Washington University
University of Pennsylvania
Hektoen Institute for Medical Research
Link to Full Grant Announcement
Grant Announcement Contact: Amy Yang [email protected]
Grants Policy

Centers for Disease Control and Prevention 404-498-2015
Similar Government Grants: • NCHHSTP Epidemiologic and Economic Modeling for HIV, Viral Hepatitis, STD, and TB; • A Bridge to Adherence: Long-Acting Antiretroviral Therapy for People with HIV Released fro...; • Improving the Quality of Life of People with HIV Aged 50 Years and Older in the United Sta...; • Understanding Infant Feeding Preferences, Practices, and Outcomes for Mothers and other Pa...; • PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Rese...; • Impact of Japanese Encephalitis Vaccination in Cambodia; • Clinical, Epidemiologic and Ecologic Factors Impacting the Burden and Distribution of Monk...; • Reduction of Malaria in U.S. Residents Returning from Overseas Travel to Malaria-Endemic C...
More Grants from the Centers for Disease Control and Prevention: • Advancing Diagnostic Network Optimization, Stepwise Laboratory Accreditation, and Integrat...; • Strengthening Public Health Systems and Services through National Partnerships to Improve ...; • 93.067; • Surveillance and Response to Avian and Pandemic Influenza by National Health Authorities o...; • Technical Assistance to Support Comprehensive Combination HIV Prevention, Care and Treatme...